Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Biotechnology

Aviceda Therapeutics

Mohamed A. Genead

Director, Financial Planning & Analysis (fp&a)

Mike Guo

Sunny Christian

Amitkumar Lad

David Callanan

Derek Kunimoto

Tarek S. Hassan

Anitha Krishnan

Michael Tolentino

The Research and Development team at Aviceda Therapeutics is dedicated to advancing innovative therapies by exploring glycobiology's potential to modulate the innate immune system. This multidisciplinary group conducts cutting-edge research, formulates drug candidates, and manages laboratory operations to develop next-generation immuno-modulators aimed at resolving chronic inflammation, with a particular focus on neurological conditions.

Research and Development

Scientific and Clinical Advisors

Leadership Team

Research and Development

About

Team members

Other teams at Aviceda Therapeutics

Scientific and Clinical Advisors

Leadership Team